Skip to content

Laboratory Blood Testing: What This Test Is, How It Is Performed, and What Your Results Mean for Your Health

Published: August 9, 2026Updated: August 16, 2026

This test detects a specific genetic change (C>T mutation) at the 4q25 chromosome location, which is associated with certain inherited eye and developmental disorders.

Quick summary

A blood or tissue sample is analyzed to look for a specific genetic mutation Results help diagnose conditions like Axenfeld-Rieger syndrome The test uses molecular genetics methods to examine your DNA Results are reported as either detected (positive) or not detected (negative)

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
92936-4
Short code
4Q25 genotyping
Synonyms
4q25 g.111710169C>T Geno Bld/T
Category
chemistry
Sample
whole-blood
Container
EDTA tube (purple top) - 6 mL draw tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 18 years
Method
molgen
CPT
81403
SNOMED
371589003
Specimen volume
3-5 mL whole blood
Stability
Room temperature: 24-72 hours; Refrigerated (2-8°C): up to 7 days; Frozen (-20°C or below): acceptable for extended storage. Avoid repeated freeze-thaw cycles.
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
72–168 hours
Order
routine

This test is a laboratory analysis, most often performed on a small sample of your blood, urine, or other body fluid. It measures specific substances in your body and helps your healthcare provider evaluate how well your organs are working, screen for certain diseases, and make informed decisions about your care.

The 4q25 g.111710169C>T genetic test is a molecular test that looks for a specific change (mutation) in your DNA at chromosome 4, position q25. This test examines whether a particular nucleotide change (from C to T) exists at position 111710169 of the genetic sequence. This specific genetic location is important because it contains the PITX2 gene, which plays a crucial role in eye development and other body systems.

A trained healthcare professional, usually a phlebotomist or nurse, will collect the sample. For a blood test, an elastic band is placed around your upper arm, the skin is cleaned, and a thin needle is inserted into a vein, most often in your arm. The sample is then sent to a laboratory for analysis, and the collection usually takes only a few minutes.

A healthcare provider will collect a small sample of your blood or tissue. For blood, this typically involves inserting a needle into a vein in your arm. For tissue, a small sample may be taken during a procedure or from an existing biopsy. The sample is then sent to a laboratory where scientists extract your DNA and use specialized molecular genetics techniques to look for the specific g.111710169C>T mutation at the 4q25 location.

Your provider may order this test as part of a routine checkup, to investigate symptoms such as fatigue, pain, fever, or unexplained weight changes, to help diagnose a medical condition, or to monitor an ongoing illness and check how well a medication or treatment is working for you.

Your doctor may recommend this test if you or your family member has symptoms or a family history of certain eye disorders, particularly Axenfeld-Rieger syndrome or related developmental conditions. The test may also be used to confirm a diagnosis, guide treatment decisions, or determine if family members are at risk. Additionally, this test may be part of a larger genetic panel when a hereditary eye condition is suspected.

Your results are compared with reference ranges, which are the values typically seen in healthy people. A result within the normal range may suggest no problem, while a value that is too high or too low can point to a condition that needs further attention. Your provider will interpret your results together with your symptoms, medical history, and other test findings, and will explain what they mean for you.

Results are typically reported as 'Detected' (positive) or 'Not Detected' (negative). If the mutation is detected, it means you have the g.111710169C>T mutation at the 4q25 location. This result can help confirm a diagnosis of associated conditions. If not detected, the specific mutation was not found, though it does not rule out other possible genetic causes for your condition. Your doctor will interpret the results in the context of your symptoms, family history, and other test findings.

The risks are generally very small. You may feel slight pain or notice bruising where the needle was inserted, and some people feel briefly lightheaded during or after the draw. Serious complications, such as infection or excessive bleeding, are rare. Let your provider know before the test if you have a bleeding disorder or take blood-thinning medications.

The risks associated with this test are minimal and are primarily related to the blood or tissue collection procedure. These may include slight pain, bruising, or bleeding at the collection site. For tissue samples, there may be slight discomfort. These risks are generally minor and temporary. The laboratory analysis itself does not pose any direct risks to you.

Reference range

Wild-type genotype (CC) - absence of the 4q25 g.111710169C>T variantN/A

Specimen: whole-blood

No special preparation required. Standard whole blood draw. Inform patient that this is a genetic test for cardiovascular risk assessment.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The 4q25 g.111710169C>T mutation is primarily associated with Axenfeld-Rieger syndrome, a group of rare genetic disorders that affect the development of the eye (particularly the anterior segment), teeth, and sometimes other body parts. Detection of this mutation can confirm diagnosis, guide management, and provide information for family planning. The PITX2 gene at this location is involved in embryonic development, and mutations can cause characteristic eye findings including anterior chamber dysplasia, posterior embryotoxon, and increased intraocular pressure. Early diagnosis allows for appropriate monitoring and treatment of associated complications.

Frequently asked questions

Is this test painful?
The blood draw may cause brief discomfort or a small pinch, but it is generally well-tolerated. The procedure only takes a few minutes.
How long does it take to get results?
Genetic test results typically take 1-4 weeks, depending on the laboratory. Your healthcare provider will contact you when results are available.
Will my insurance cover this test?
Coverage varies by insurance plan and the clinical reason for testing. We recommend contacting your insurance company to understand your benefits before the test.
Do I need to fast before this test?
No, fasting is not required for this genetic test. You can eat and drink normally before the sample collection.
What happens if the test is positive?
A positive result confirms the presence of the mutation. Your doctor will discuss what this means for your health, recommend appropriate follow-up care, and may suggest testing for family members.
Can children have this test?
Yes, this test can be performed on individuals of any age, including children, if there is a clinical indication based on symptoms or family history.
  1. 1
  2. 2

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy